Large molecule analysis
latest technologies. flexible solutions.
Significant experience in the development and validation of immunoassays for large molecules and biomarkers gives inVentiv Health Clinical scientists special insight into biotechnology product development. Work performed in our GLP-compliant immunochemistry facilities includes proprietary and non-proprietary pharmacokinetic and immunogenicity assays, as well as a wide range of cell-based and enzymatic assays. By rapidly providing specialized immunogenicity testing for the presence of antibodies to biologic and biosimilar products, inVentiv Health Clinical can help move your large molecule development programs forward quickly and smoothly.
Our technology and experience allows applications of a variety of immunoassay platforms including:
inVentiv Health Clinical provides a growing menu of standard and custom assays optimized for the quantitation of multiple analytes (proteins) in serum, EDTA, and heparin, as well as sodium citrate plasma, culture supernatant, and other sample types. Our immunoassay capabilities include single analytes and multiplexing.